Pharma & Biotech

Tempus AI finds itself navigating a rapidly evolving sector, where regulatory approvals, strategic expansion, and upcoming financial disclosures are key...

Capricor Therapeutics finds itself navigating turbulent waters as a federal securities class action lawsuit casts uncertainty over the company's future....

Today represents a pivotal moment for Apellis Pharmaceuticals as the market awaits its third-quarter 2025 financial results. This earnings report...

Shares of Veru experienced severe volatility after the company revealed plans to raise capital through a public securities offering. The...

Novo Nordisk's stock is experiencing a significant downturn as multiple challenges converge on the Danish pharmaceutical giant. Investor confidence has...

Investors are showing renewed confidence in Ardelyx following the release of compelling new clinical data for its treatment IBSRELA. The...

Time is running out for investors in CureVac as they approach a decisive moment in the company's proposed acquisition by...

Healwell AI has significantly enhanced its market position through a strategic expansion of its existing partnership with WELL Health Technologies....

The ARK Innovation ETF (ARKK) continues to position itself at the forefront of transformative technologies, operating within a rapidly evolving...

Nuvation Bio shares continue their impressive upward trajectory, establishing fresh momentum this week. The stock achieved a new 52-week peak...